Skip to content

What is drug abandonment? Understanding a Critical Healthcare Issue

5 min read

According to a 2024 IQVIA report, 98 million new therapy prescriptions were abandoned by patients in 2023, highlighting a pervasive and costly healthcare problem. This phenomenon, often driven by a variety of systemic and personal factors, begs the question: what is drug abandonment?.

Quick Summary

Drug abandonment is the failure of a patient to obtain a new or refilled prescription after it has been sent to the pharmacy. It is a critical form of medication non-adherence with significant health and economic consequences for patients and the healthcare system.

Key Points

  • Definition: Drug abandonment is the failure of a patient to collect a prescribed medication, also known as primary non-adherence.

  • High Costs: Financial burdens, including high copayments and deductibles, are the leading cause, with abandonment rates increasing significantly as out-of-pocket costs rise.

  • Healthcare Impact: Poor adherence from abandonment leads to an estimated 125,000 avoidable deaths and $300 billion in annual healthcare costs in the U.S..

  • Contributing Factors: Beyond cost, other causes include patient forgetfulness, complex prior authorization processes, access issues, and patient beliefs about the medication.

  • Pharmacist Intervention: Pharmacists can play a crucial role by offering patient assistance programs, digital reminders, and exploring cost-effective alternatives.

  • Provider Responsibility: Healthcare providers should discuss costs upfront and help navigate prior authorizations to prevent abandonment at the point of prescribing.

  • Broader Context: Drug abandonment is the initial hurdle in medication adherence, which can worsen health outcomes and disease progression.

In This Article

What is Drug Abandonment?

Drug abandonment, also known as primary medication non-adherence, refers to the situation where a patient fails to pick up a newly prescribed or refilled medication from the pharmacy. Unlike secondary non-adherence, where a patient starts but then stops or improperly takes a medication, abandonment represents a complete breakdown in the patient's treatment journey before it even begins. This can happen at different points along the way, from a patient forgetting to bring a paper prescription to the pharmacy, to walking away from the counter after being informed of a high cost.

The Silent Healthcare Crisis

The scale of drug abandonment is a major contributor to the broader issue of medication non-adherence. Estimates suggest that poor medication adherence in the U.S. causes roughly 125,000 avoidable deaths annually and is associated with hundreds of billions of dollars in avoidable healthcare costs. Forgoing essential medications can lead to worsening health conditions, increased hospitalizations, and other severe health complications.

Key Causes of Drug Abandonment

Drug abandonment is a complex problem with multiple interconnected causes. Understanding these root issues is the first step toward effective intervention.

  • High Out-of-Pocket Costs: Cost is arguably the most significant barrier. When confronted with high copayments, deductibles, or unexpectedly high prices, many patients, even those with insurance, are forced to make difficult financial choices. An IQVIA study found that 69% of commercial patients facing costs over $250 did not start therapy.
  • Lack of Price Transparency: Patients are often unaware of the actual cost of their medication until they arrive at the pharmacy. This 'sticker shock' can lead to immediate abandonment, especially for high-cost or specialty drugs.
  • Patient Forgetfulness: Forgetting to pick up a new prescription or a scheduled refill is a common and simple cause of abandonment. This is especially prevalent in the age of electronic prescribing, where the patient is less actively involved in physically delivering the script.
  • Prior Authorization Delays and Complexity: The process of prior authorization, required by many insurance plans, is often confusing and time-consuming. Research indicates that complex authorization processes frequently lead to treatment abandonment.
  • Patient Beliefs and Concerns: Misinformation, medical anxiety, or skepticism about the medication can lead patients to doubt its necessity or safety. This is particularly true for asymptomatic conditions, like high blood pressure, where patients may not feel the need to continue taking medication because they don't perceive an immediate benefit.
  • Side Effects: Real or perceived adverse effects can make patients hesitant to start a new medication, leading them to abandon the prescription at the pharmacy counter.
  • Access and Logistical Barriers: Issues like a lack of reliable transportation, living in a 'pharmacy desert,' or mobility problems can make it difficult for patients to physically get to the pharmacy.

Consequences of Drug Abandonment

The decision to abandon a prescription has far-reaching consequences that affect individuals, healthcare systems, and the overall economy.

Negative Health Outcomes

For patients, abandoning therapy can have severe health consequences, particularly for those managing chronic conditions such as diabetes, hypertension, or high cholesterol. Worsening symptoms, disease progression, and the need for more costly and intensive medical interventions, like hospitalizations, are direct results of non-adherence. In some cases, abruptly discontinuing certain medications can even lead to dangerous withdrawal symptoms.

Significant Economic Burden

Beyond individual health, medication abandonment places a massive financial strain on the healthcare system. The costs include not only wasted medications and pharmacy resources but also the expenses associated with treating the worsened health conditions that result from lack of treatment.

Systemic Inefficiency

From a logistical standpoint, abandoned prescriptions require pharmacies to return inventory to stock, which consumes valuable time and resources. Furthermore, if a provider's electronic health record indicates a prescription was sent to the pharmacy but the patient never picked it up, it can create inaccuracies in the patient's medical history. This could lead a doctor to prescribe an alternative drug, potentially causing further complications.

Drug Abandonment vs. Other Non-Adherence

Feature Drug Abandonment (Primary Non-Adherence) Secondary Non-Adherence
Definition A patient never obtains the initial or a refill prescription from the pharmacy. A patient obtains the medication but fails to take it as prescribed (e.g., skipping doses, stopping early).
Timing Occurs at the beginning of the treatment course or at the point of refill. Occurs during the ongoing course of treatment after the initial fill.
Primary Cause Often driven by external factors like cost, prior authorization, and access issues. Can be influenced by internal factors like forgetfulness, side effects, or a patient's belief about the medication's effectiveness.
Patient Involvement Patient does not actively engage with the medication after the prescription is sent. Patient actively disengages with the medication after starting treatment.

Strategies to Combat Drug Abandonment

Addressing this issue requires a multi-pronged approach involving healthcare providers, pharmacists, and pharmaceutical companies working together.

Role of Healthcare Providers

  1. Enhance Communication: Initiate open, non-judgmental conversations with patients about potential barriers, including cost and side effects.
  2. Increase Price Transparency: Utilize real-time benefit check software to provide patients with an accurate estimate of their out-of-pocket costs at the point of prescribing.
  3. Simplify Prior Authorization: Streamline the prior authorization process and consider alternative, more accessible therapies if delays are expected.
  4. Explore Cost-Effective Options: Discuss generic alternatives or manufacturer-sponsored copay assistance programs with patients before they leave the office.

Role of Pharmacies

  1. Proactive Patient Engagement: Implement digital engagement strategies, such as text message reminders for pick-up, to combat forgetfulness.
  2. Provide Affordability Solutions: Train staff to help patients navigate copay assistance programs or explore cash pricing mechanisms to lower out-of-pocket costs.
  3. Offer Convenient Services: Provide mail-order delivery and automatic refill options to overcome transportation and logistical barriers.

Role of Pharmaceutical Companies and Systems

  1. Invest in Patient Assistance Programs: Offer robust patient assistance programs to reduce or eliminate medication costs for eligible patients.
  2. Develop Digital Adherence Platforms: Create tools that help patients manage their medication regimens and stay engaged with their therapy.

Conclusion

Drug abandonment is a complex, systemic issue with significant negative health and economic impacts. Its causes are varied, ranging from simple forgetfulness to complex financial and logistical barriers. By improving communication, enhancing price transparency, and leveraging patient support programs, healthcare providers, pharmacists, and health systems can collaboratively work to reduce abandonment rates. Ultimately, a concerted effort is required to ensure that a prescription written is a prescription filled, and that all patients have equitable access to the medications they need for optimal health outcomes.

For more information on addressing medication access issues, explore strategies on improving patient adherence through programs offered by the PAN Foundation.

Frequently Asked Questions

Drug abandonment is a specific type of medication non-adherence, referring to primary non-adherence where a patient never obtains the initial prescription fill. Non-adherence is a broader term that also includes secondary non-adherence, where a patient starts but does not continue or correctly take a medication.

Patients often abandon prescriptions due to cost when they face high out-of-pocket expenses, such as large copayments or unmet deductibles. Confronted with 'sticker shock' at the pharmacy, many are forced to prioritize other financial needs over their medication.

Providers can prevent drug abandonment by discussing potential costs with patients at the point of prescribing, using real-time benefit checks, and helping navigate complex prior authorization processes. Enhanced patient education also helps address concerns and misinformation.

Yes, studies have shown that electronic prescribing can sometimes correlate with higher rates of prescription abandonment. This may be due to the patient's more passive role in the process, making it easier for them to forget or remain uninformed about the prescription details.

Patient assistance programs (PAPs) are highly effective in reducing drug abandonment by making medications more affordable. They offer financial support, such as copay cards or free drugs, which can remove cost-related barriers and improve access.

Drug abandonment results in billions of dollars in avoidable healthcare costs each year, primarily due to worsened patient health outcomes and subsequent medical care needs. It also creates systemic inefficiencies for pharmacies, such as the resources spent returning unclaimed medications to stock.

If a patient cannot afford their medication, they should speak with their doctor or pharmacist. They can discuss potential generic or therapeutic alternatives, look into patient assistance programs, or explore manufacturer-sponsored copay cards that may lower out-of-pocket costs.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.